Hikma Pharmaceutical | HIK - Debt

Stock Price
1,437.00
Daily Change
-3.00 -0.21%
Monthly
4.32%
Yearly
-30.51%
Q2 Forecast
1,414.37

Hikma Pharmaceutical reported $1.56B in Debt for its fiscal semester ending in June of 2025.





Debt Change Date
Almirall EUR 342.86M 61.94M Dec/2025
argenx SE USD 47.16M 4.01M Dec/2025
AstraZeneca USD 33.92B 4.3B Mar/2026
Autolus Therapeutics Ltd USD 253.44M 8.84M Mar/2025
Bayer EUR 36.45B 2.93B Dec/2025
Fresenius EUR 11.93B 919M Dec/2025
Genmab DKK 148M 5M Jun/2025
GlaxoSmithKline GBP 19.06B 1.34B Mar/2026
GRIFOLS EUR 9.57B 746.56M Dec/2025
Hikma Pharmaceutical USD 1.56B 252M Jun/2025
Lakefront Biotherapeutics EUR 6.44M 480K Mar/2026
Lonza CHF 4.71B 915M Dec/2024
Merck EUR 11.95B 152M Dec/2025
Orion EUR 305.4M 15.8M Dec/2025
Recordati EUR 2.47B 37.48M Dec/2025
Roche Holding CHF 33.03B 1.41B Jun/2025
Sanofi EUR 20.33B 1.43B Dec/2025
UCB EUR 3.03B 12M Dec/2024